Find a Tender · Historical
Western Health and Social Care Trust
NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections
Historical: no longer open for bids.
01/ The notice
Key facts
- Value
- Not statedValue not stated in source
- Deadline (UK time)
- No open deadlineA deadline does not apply to this historical notice.
- Published
- 23 Aug 2024
- Region
- Not stated
02/ The brief
What the notice says
Not fully read: this is the notice text; attached documents are not read.
Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.
03/ Classification
CPV codes
Common Procurement Vocabulary codes, exactly as the notice lists them. No descriptions are added here.
- 33600000
04/ History
Releases of this notice
One release held, oldest first. Dates are UK time.
- 23 Aug 2024Award notice
Award notice published 23 August 2024.
Release 027072-2024
View this release on Find a Tender (opens in a new tab)
05/ Limits
What the source does not tell us
- The source does not state a usable value.
- Only one release is held, so there is no change history.
06/ Questions
About this notice
07/ Related
Where to go next
These links follow a fixed rule applied to this notice’s buyer, text and CPV codes. They are not advice on whether to bid.
- Reference
- ocds-h6vhtk-049390
- Source
- Find a Tender
- Stage
- award · Awarded
- Last verified
- Mon 6 Apr 2026, 15:36 BST
- Read at
- Sat 17 Oct 2026, 01:53 BST
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Built on published notices from Find a Tender and Contracts Finder.